Information For Authors
Submitting Your Manuscript
Advances in Wound Care aims to fill a gap in bridging the different disciplines necessary to support wound research and care. It provides a unique forum for the field of tissue injury and repair, with an emphasis on acute and chronic skin wound care to optimize patient outcomes. Bench-based mechanistic studies are welcome as long authors are willing to include a section in Discussion addressing the findings in the context of wound care. The Journal enables rapid dissemination of translational research from bench to bedside, with wound care applications including burns, major trauma, blast injuries, surgery, diabetic ulcers, ostomy, bedsores, and more. Advances in Wound Care supports public-academia-private partnership, the success of which is critical to improve wound care outcomes.
Advances in Wound Care welcomes review articles, both short critical treatise as well as comprehensive reviews. The Technology Advances track is dedicated to addressing product development for clinical care as well as to novel methodologies for research advancement. The News and Views track will report newsworthy developments in the wound care community. Discovery Express will rapidly publish original research articles of outstanding importance. For this track, submission to first decision time will not exceed 2 weeks. Mechanistic studies are well received by the peer review process.
Advances in Wound Care can only accept highly competitive articles. All submissions, other than those in the News and Views track, are subject to peer review by 2-4 reviewers on an average.
Manuscripts that are not formatted strictly according to the guidelines described herein will be administratively rejected without any peer review.
ORCID IDs
The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Advances in Wound Care before logging in with an ORCID identifier.
Manuscript Submission Site
Create an Account in ScholarOne
If you do not already have an account in ScholarOne for Advances in Wound Care, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.
Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Advances in Wound Care. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.
CLICK HERE TO SUBMIT YOUR MANUSCRIPT
See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT
Check the Journal’s PEER REVIEW POLICIES
Note: Just Accepted / Instant Online Publication
Advances in Wound Care publishes all accepted papers within 72 hours of receipt of all authors' signed copyright agreement forms in their unedited, uncorrected format.
It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that are populated into the fields in ScholarOne – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review. Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision* of the article is published. As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission. Any omissions or errors will remain on our website and in indexing services until the subsequent online version is published.
*The next revision will take place after the corresponding author reviews page proofs, makes any necessary corrections, and returns the changes to the Publisher. Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.
Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.
NOTE: Supplemental Information, if supplied, will NOT be published in the Just Accepted/LION platform, but instead will be published in the Online Now (epub) and final versions of the article. Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)
Manuscript Preparation
Determining Authorship
(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.
Submission Process
Only senior authors of a work who take complete scientific as well as financial responsibility of a submission may submit the work. Manuscripts cannot be submitted on behalf of the corresponding author by any agent other than the corresponding author's own office.
CLICK HERE FOR ARTICLE TYPES AND WORD LIMITS
All Original submissions must contain:
An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
Acknowledgments section (if applicable) after the Conclusion of the manuscript, followed by
An Author Contribution statement for each listed author, followed by
An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
Funding statement(s), even if there is no funding information to declare.
See IRB APPROVALS, PATIENT CONSENT, & ETHICAL TREATMENT OF ANIMALS
See AUTHOR CONFIRMATION AND DISCLOSURE STATEMENTS
See FUNDING INFORMATION: COMPLIANCE AND STATEMENTS
Ethics of experimentation
The Journal endorses the principles embodied in the Declaration of Helsinki and insists that all investigations involving humans be conducted in conformity with these principles. All animal experimentation reported must be conducted in conformity with internationally accepted principles. Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements. The senior author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely, and the standards conformed to those of current ethical animal research practices.
In describing surgical procedures, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided that anesthesia of suitable grade and duration was employed. All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. Editors are expected to reject articles in which evidence of the adherence to these principles is not apparent. They reserve the right to judge the appropriateness of the use of animals and humans in experiments. The Editors-in-Chief will adjudicate differences of opinion employing principles consistent with the content posted at: http://ethics.od.nih.gov/
Protection of Research Participants
All manuscripts must comply with the Protection of Research Participants requirements outlined in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, written informed consent must be obtained). Masking the subjects’ eyes in photographs is inadequate protection of anonymity. For more information, visit http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html
All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. www.icmje.org
When submitting your manuscript for peer review, be prepared to:
Enter the full title of the manuscript
Enter the full names and institutional affiliations of ALL listed authors
Enter ALL listed authors' institutional email addresses
Identify the corresponding author
Enter a running (abbreviated) title of no more than 50 characters (including spaces).
Enter 3–6 keywords or phrases to assist in the selection of skilled reviewers in the field for the purposes of peer review.
Provide an abstract of no more than 250 words (the format varies according to the article type; see below)
Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
Confirm that the material has not been published or submitted for publication elsewhere.
Cover Letter
The submitting author must accept responsibility for the following:
The submitting author has the written consent from all authors to submit the manuscript and that all authors accept complete responsibility for the contents of the manuscript.
The manuscript has not been previously published, or is not currently under consideration elsewhere, and that the work reported will not be submitted for publication elsewhere until a final decision has been made as to its acceptability by Advances in Wound Care (note that posting of submitted material on a website is considered pre-publication).
The manuscript is truthful original work.
Create an Effective Title
Manuscript titles should be brief, contain key terms, and clearly identify the purpose
of the work conducted
Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
Avoid the use of specific locations in the title
Do not use proprietary/trademarked names in the title
Do not use acronyms in the title unless they are universally recognized and accepted
NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).
File Naming
All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
Title page (with full manuscript title, all contributing authors and their affiliations, a short running title, a denotation of the corresponding author, and a list of 3-6 keywords). Specify the type of article. Where necessary, identify each author’s affiliation by superscript numbers matched to the appropriate institution. Please list the article word count (excluding abstract, references, and figure legends).
Abstract
Main text (do not embed figures or tables)
Conclusion (if applicable; as a separate paragraph, not as part of the Discussion section)
Acknowledgments (if applicable)
Authorship confirmation statement (see below)
Author(s’) disclosure statement(s) (see below)
Funding statement (see below)
About the authors
Abbreviations and acronyms
References
Figure legends
Tables
Supplemental files (if applicable; supplied in Word, not as a PDF)
Note: The keywords are search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article. If the search terms entered do not match the manuscript, the manuscript will serve as the default.
Abstract
For Review articles, the abstract should consist of the following sections: Significance, Recent Advances, Critical Issues, and Future Directions. For Discovery Express and Technology Advances articles, the abstract should consist of the following sections: Objective, Approach, Results, Innovation, and Conclusion. For News and Views articles, the abstract does not need to be structured with headings. Submissions with abstracts longer than 250 words will not be considered for publication.
Manuscript Text
The maximum word count and organization of the text vary according to the article type (see below). Manuscripts should be written succinctly and should cite select references that are directly relevant. The text should be clear and concise, conforming to accepted standards of English style and usage.
Number pages (bottom-center) consecutively; the first author’s last name should appear on each page. The source of cells utilized (species, sex, strain, race, age of donor, whether primary or established) should be clearly indicated. The source of reagents should be stated (name, city, and state within parentheses) when first cited. Publication of results is based on the principle that results must be verifiable. Authors must expect to make unique reagents available to qualified investigators either directly or through a recognized distributor.
For Discovery Express and Technology Advances, the abstract should be followed by the following sections: Introduction, Innovation, Clinical Problem Addressed (even if it is basic science research, highlight what clinical problem is the work relevant to), Materials and Methods, Results (for the Technology Advances track provide a schematic diagram of the device as appropriate), Discussion, Key Findings (present as an itemized bullet list of 3-4 major findings), Acknowledgments, Author Confirmation, Author Disclosure and Ghostwriting, Funding Statement, About the Authors, Abbreviations and Acronyms, References, Figure legends, and Tables. Begin each of these sections on a separate page. The Innovation section cannot exceed 100 words and cannot be diffused. In 4-6 sentences it must summarize the current state of the field and then cite specific results reported to explain how this work helps to substantially advance the field. If the work has clinical significance, please be sure to highlight that. Do not regurgitate findings.
Illustrations: Continuous data cannot be presented as bar and line graphs. Bar and line graphs must show scatter plot revealing each data point.
The INNOVATION section must include a simplified summary graphic illustration (Fig. 1 in all submissions) in this section to highlight major advances. This illustration must be brief and simple intended to communicate the core message to readers outside the specific area of expertise. Highlight key advances.
……
更多详情：
https://home.liebertpub.com/publications/advances-in-wound-care/605/for-authors
